-
1
-
-
84884755163
-
The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis
-
Ostergaard L, Tietze A, Nielsen T, et al. The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis. Cancer Res. 2013; 73: 5618-5624. Doi:10.1158/0008-5472.CAN-13-0964 [doi].
-
(2013)
Cancer Res.
, vol.73
, pp. 5618-5624
-
-
Ostergaard, L.1
Tietze, A.2
Nielsen, T.3
-
2
-
-
1242317693
-
The SLC2 family of facilitated hexose and polyol transporters
-
Uldry M and Thorens B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch. 2004; 447: 480-489. Doi:10.1007/s00424-003-1085-0
-
(2004)
Pflugers Arch.
, vol.447
, pp. 480-489
-
-
Uldry, M.1
Thorens, B.2
-
3
-
-
0036077547
-
Glucose transporters: expression, regulation and cancer
-
Medina RA and Owen GI. Glucose transporters: expression, regulation and cancer. Biol.Res. 2002; 35: 9-26.
-
(2002)
Biol.Res.
, vol.35
, pp. 9-26
-
-
Medina, R.A1
Owen, G.I.2
-
4
-
-
84872478184
-
Expression of glucose transporters in cancers
-
Szablewski L. Expression of glucose transporters in cancers. Biochim. Biophys.Acta. 2013; 1835: 164-169. Doi:10.1016/j.bbcan.2012.12.004; 10.1016/j.bbcan.2012.12.004.
-
(2013)
Biochim. Biophys.Acta.
, vol.1835
, pp. 164-169
-
-
Szablewski, L.1
-
5
-
-
33646342485
-
Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues
-
Godoy A, Ulloa V, Rodriguez F, et al. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J.Cell.Physiol. 2006; 207: 614-627. Doi:10.1002/jcp.20606.
-
(2006)
J.Cell.Physiol.
, vol.207
, pp. 614-627
-
-
Godoy, A.1
Ulloa, V.2
Rodriguez, F.3
-
6
-
-
0032875964
-
Expression of facilitative glucose transporters in gastric tumors
-
Noguchi Y, Marat D, Saito A, et al. Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology. 1999; 46: 2683-2689.
-
(1999)
Hepatogastroenterology.
, vol.46
, pp. 2683-2689
-
-
Noguchi, Y.1
Marat, D.2
Saito, A.3
-
7
-
-
37249067628
-
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
-
Evans A, Bates V, Troy H, et al. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother. Pharmacol. 2008; 61: 377-393. Doi:10.1007/s00280-007-0480-1.
-
(2008)
Cancer Chemother. Pharmacol.
, vol.61
, pp. 377-393
-
-
Evans, A.1
Bates, V.2
Troy, H.3
-
8
-
-
22344433208
-
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts
-
Airley RE, Phillips RM, Evans AE, et al. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int.J.Oncol. 2005; 26: 1477-1484.
-
(2005)
Int.J.Oncol.
, vol.26
, pp. 1477-1484
-
-
Airley, R.E.1
Phillips, R.M.2
Evans, A.E.3
-
9
-
-
77952741529
-
Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays
-
Airley R, Evans A, Mobasheri A and Hewitt SM. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. Ann.Anat. 2010; 192: 133-138. Doi:10.1016/j.aanat.2010.03.001 [doi].
-
(2010)
Ann.Anat.
, vol.192
, pp. 133-138
-
-
Airley, R.1
Evans, A.2
Mobasheri, A.3
Hewitt, S.M.4
-
10
-
-
84879420411
-
The facilitative glucose transporter GLUT12: what do we know and what would we like to know?
-
Pujol-Gimenez J, Barrenetxe J, Gonzalez-Muniesa P and Lostao MP. The facilitative glucose transporter GLUT12: what do we know and what would we like to know? J.Physiol.Biochem. 2013; 69: 325-333. Doi:10.1007/s13105-012-0213-8; 10.1007/s13105-012-0213-8.
-
(2013)
J.Physiol.Biochem.
, vol.69
, pp. 325-333
-
-
Pujol-Gimenez, J.1
Barrenetxe, J.2
Gonzalez-Muniesa, P.3
Lostao, M.P.4
-
11
-
-
53149137389
-
Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II
-
Stockhammer F, von Deimling A, Synowitz M, Blechschmidt C and van Landeghem FKH. Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II. Journal of Molecular Histology. 2008; 39: 553-560. Doi:10.1007/s10735-008-9191-0 ER.
-
(2008)
Journal of Molecular Histology.
, vol.39
, pp. 553-560
-
-
Stockhammer, F.1
von Deimling, A.2
Synowitz, M.3
Blechschmidt, C.4
van Landeghem, F.K.H.5
-
12
-
-
82355164170
-
Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer
-
Zawacka-Pankau J, Grinkevich VV, Hunten S, et al. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer. J.Biol.Chem. 2011; 286: 41600-41615. Doi:10.1074/jbc.M111.240812.
-
(2011)
J.Biol.Chem.
, vol.286
, pp. 41600-41615
-
-
Zawacka-Pankau, J.1
Grinkevich, V.V.2
Hunten, S.3
-
15
-
-
34247144041
-
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues
-
Suganuma N, Segade F, Matsuzu K and Bowden DW. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues. BJU Int. 2007; 99: 1143-1149. Doi:10.1111/j.1464-410X.2007.06765.x ER.
-
(2007)
BJU Int.
, vol.99
, pp. 1143-1149
-
-
Suganuma, N.1
Segade, F.2
Matsuzu, K.3
Bowden, D.W.4
-
16
-
-
0030610567
-
Immunohistochemical detection of Glut3 in human tumors and normal tissues
-
Younes M, Lechago LV, Somoano JR, Mosharaf M and Lechago J. Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res. 1997; 17: 2747-2750.
-
(1997)
Anticancer Res.
, vol.17
, pp. 2747-2750
-
-
Younes, M.1
Lechago, L.V.2
Somoano, J.R.3
Mosharaf, M.4
Lechago, J.5
-
18
-
-
0141838090
-
GLUT12 expression in human placenta in first trimester and term
-
Gude NM, Stevenson JL, Rogers S, et al. GLUT12 expression in human placenta in first trimester and term. Placenta. 2003; 24: 566-570. Doi:10.1053/plac.2002.0925 ER.
-
(2003)
Placenta.
, vol.24
, pp. 566-570
-
-
Gude, N.M.1
Stevenson, J.L.2
Rogers, S.3
-
19
-
-
1842858245
-
Expression and localisation of GLUT1 and GLUT12 glucose transporters in the pregnant and lactating rat mammary gland
-
Macheda ML, Williams ED, Best JD, Wlodek ME and Rogers S. Expression and localisation of GLUT1 and GLUT12 glucose transporters in the pregnant and lactating rat mammary gland. Cell Tissue Res. 2003; 311: 91-97. Doi:10.1007/s00441-002-0661-5.
-
(2003)
Cell Tissue Res.
, vol.311
, pp. 91-97
-
-
Macheda, M.L.1
Williams, E.D.2
Best, J.D.3
Wlodek, M.E4
Rogers, S.5
-
20
-
-
12344312943
-
Expression of GLUT12 in the fetal membranes of the human placenta
-
Gude NM, Stevenson JL, Murthi P, et al. Expression of GLUT12 in the fetal membranes of the human placenta. Placenta. 2005; 26: 67-72. Doi:10.1016/j.placenta.2004.04.006 ER.
-
(2005)
Placenta.
, vol.26
, pp. 67-72
-
-
Gude, N.M.1
Stevenson, J.L.2
Murthi, P.3
-
21
-
-
0032508679
-
Multicellular spheroids as an in vitro tumor model
-
Hamilton G. Multicellular spheroids as an in vitro tumor model. Cancer Lett. 1998; 131: 29-34.
-
(1998)
Cancer Lett.
, vol.131
, pp. 29-34
-
-
Hamilton, G.1
-
22
-
-
77953916745
-
Multicellular tumor spheroids: an underestimated tool is catching up again
-
Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W and Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J.Biotechnol. 2010; 148: 3-15. Doi:10.1016/j.jbiotec.2010.01.012; 10.1016/j.jbiotec.2010.01.012.
-
(2010)
J.Biotechnol.
, vol.148
, pp. 3-15
-
-
Hirschhaeuser, F.1
Menne, H.2
Dittfeld, C.3
West, J.4
Mueller-Klieser, W.5
Kunz-Schughart, L.A.6
-
23
-
-
0030865104
-
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
-
O'Connor PM, Jackman J, Bae I, et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 1997; 57: 4285-4300.
-
(1997)
Cancer Res.
, vol.57
, pp. 4285-4300
-
-
O'Connor, P.M.1
Jackman, J.2
Bae, I.3
-
24
-
-
70249100296
-
MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53
-
Canner JA, Sobo M, Ball S, et al. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. Br.J.Cancer. 2009; 101: 774-781. Doi:10.1038/sj.bjc.6605199 [doi].
-
(2009)
Br.J.Cancer.
, vol.101
, pp. 774-781
-
-
Canner, J.A.1
Sobo, M.2
Ball, S.3
-
25
-
-
0034965384
-
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells
-
Tweddle DA, Malcolm AJ, Cole M, Pearson AD and Lunec J. p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am.J.Pathol. 2001; 158: 2067-2077. Doi:S0002-9440(10)64678-0 [pii].
-
(2001)
Am.J.Pathol.
, vol.158
, pp. 2067-2077
-
-
Tweddle, D.A.1
Malcolm, A.J.2
Cole, M.3
Pearson, A.D4
Lunec, J.5
|